Translating molecular advances in Down syndrome and Fragile X syndrome into therapies

Faundez, V; De Toma, I; Bardoni, B; Bartesaghi, R; Nizetic, D; de la Torre, R; Cohen Kadosh, R; ... Strydom, A; + view all Faundez, V; De Toma, I; Bardoni, B; Bartesaghi, R; Nizetic, D; de la Torre, R; Cohen Kadosh, R; Herault, Y; Dierssen, M; Potier, MC; Antonarakis, S; Bartesaghi, R; Contestabile, A; Coppus, T; De Deyn, P; Dekker, A; Delabar, JM; Dierssen, M; Fisher, E; Hérault, Y; Martinez-Cué, C; Potier, MC; Strydom, A; - view fewer (2018) Translating molecular advances in Down syndrome and Fragile X syndrome into therapies. European Neuropsychopharmacology , 28 (6) pp. 675-690. 10.1016/j.euroneuro.2018.03.006 .

https://ift.tt/2L02peA